Accession Number: | 0001209191-23-007503 |
Date: | 2023-02-06 |
Issuer: | FATE THERAPEUTICS INC (FATE) |
Original Submission Date: |
DULAC EDWARD J III
C/O FATE THERAPEUTICS, INC.
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO, CA 92131
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 6.77 | 2023-02-06 | deemed execution date | A | 425,000 (a) | 2033-02-05 | common stock 425,000 | $6.77 | 425,000 | direct |
ID | footnote |
---|---|
f1 | the shares subject to this option shall vest in 36 equal monthly installments following january 1, 2023, such that all of the shares shall be fully vested and exercisable on january 1, 2026, subject to the reporting person's continued service with the issuer as of each such vesting date. |